4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-072481
Director acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Coleman Mark · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-23 | Exercise or conversion : show line 1 in the form | +6,250 | $4.95 | $30,938 | 72,140 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-23 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −6,250 | 7,721 | D |
Loading xslF345X05/ownership.xml…